ClinConnect ClinConnect Logo
Search / Trial NCT04374162

Driving Pressure in Laparoscopic Surgery

Launched by CAPITAL MEDICAL UNIVERSITY · Apr 30, 2020

Trial Information

Current as of August 20, 2025

Completed

Keywords

ClinConnect Summary

After screened for preoperative risk factors, 48 patients undergoing elective laparoscopic surgery and planned to be extubated in the operating room are randomly assigned to two groups: (1) PEEP = 5cmH2O; (2) driving pressure (DP)-guided PEEP. The ventilation protocol consists of volume-controlled mechanical ventilation (Datex Ohmeda S/5 Advance; General Electric Company Healthcare, Helsinki, Finland) at a tidal volume (VT) of 8 ml/kg predicted body weight (PBW), fresh gas of 2 litre /min, inspiratory to expiratory ratio of 1:2, and a respiratory rate adjusted to normocapnia (arterial carbo...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed consent has been obtained
  • Elective laparoscopic surgery with Trendelenburg position
  • Expected ventilation duration \> 2 hours
  • Scheduled to be extubated in the operation
  • Exclusion Criteria:
  • Mechanical ventilation of \> 1 hour within the last 2 weeks before surgery
  • Body mass index ≥ 35 kg/m2
  • Acute respiratory failure (pneumonia, acute lung injury or acute respiratory distress syndrome)
  • Emergency surgery
  • Severe cardiac disease
  • Progressive neuromuscular illness
  • Pregnancy
  • Refusal to participate
  • Contradicted to EIT scan

About Capital Medical University

Capital Medical University is a leading institution in medical education and research, dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with a network of healthcare professionals and researchers to drive breakthroughs in medical science. Capital Medical University aims to enhance patient care and improve health outcomes by fostering a multidisciplinary approach to clinical research, ensuring that its trials are designed to address critical health challenges and contribute valuable insights to the medical community.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Ruquan Han, MD,PHD

Study Director

Beijing Tiantan Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials